Columbia Wanger Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-294,991
Closed -$9.09M 206
2016
Q4
$9.09M Sell
294,991
-264,480
-47% -$8.18M 0.13% 177
2016
Q3
$16.9M Sell
559,471
-241,406
-30% -$7.28M 0.22% 151
2016
Q2
$21.9M Buy
800,877
+196,242
+32% +$5.02M 0.25% 140
2016
Q1
$16.2M Buy
+604,635
New +$14.8M 0.17% 151

Other funds holding RGEN

Columbia Wanger Asset Management's RGEN Position: Q1 2017 in Review

Columbia Wanger Asset Management sold out of Repligen (RGEN) in Q1 2017, closing a stake of 294,991 shares — an estimated $9.09M sold.

Columbia Wanger Asset Management first reported a position in RGEN in Q1 2016 and held it in 4 quarters. The position peaked at $21.9M in Q2 2016. 180 funds tracked by Wall St. Rank hold RGEN as of Q1 2017.

  • Columbia Wanger Asset Management reported no remaining Repligen position as of Q1 2017 after selling out during the quarter.
  • Columbia Wanger Asset Management sold 294,991 Repligen shares in Q1 2017, an estimated $9.09M.
  • Columbia Wanger Asset Management first reported a position in Repligen in Q1 2016 and held it in 4 quarters.
  • Columbia Wanger Asset Management's Repligen position peaked at $21.9M in Q2 2016.
  • 180 funds tracked by Wall St. Rank held Repligen as of Q1 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q1 2017, filed 12 May 2017.